Angiopoietins promote ovarian cancer progression by establishing a procancer microenvironment

American Journal of Pathology

Volumn 184, Issue 8, 2014, Pages 2285-2296

  Brunckhorst, Melissa K ^a   Xu, Yin ^a   Lu, Rong ^a   Yu, Qin ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN 4; ANGIOPOIETIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; ANIMAL; CYSTADENOCARCINOMA; DISEASE COURSE; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; XENOGRAFT;

ANGIOPOIETINS; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTADENOCARCINOMA, SEROUS; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, TIE-2; TUMOR MICROENVIRONMENT;

EID: 84904690619     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.05.006     Document Type: Article

References (51)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. K.H. Baumann, U. Wagner, and A. du Bois The changing landscape of therapeutic strategies for recurrent ovarian cancer Future Oncol 8 2012 1135 1147
3. M.K. Brunckhorst, D. Lerner, S. Wang, and Q. Yu AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer Cancer Biol Ther 13 2012 804 811
4. C. Aghajanian The role of bevacizumab in ovarian cancer-an evolving story Gynecol Oncol 102 2006 131 133
5. E.S. Han, and B.J. Monk Bevacizumab in the treatment of ovarian cancer Expert Rev Anticancer Ther 7 2007 1339 1345
6. T.M. Numnum, R.P. Rocconi, J. Whitworth, and M.N. Barnes The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma Gynecol Oncol 102 2006 425 428
7. A.A. Alvarez, H.R. Krigman, R.S. Whitaker, R.K. Dodge, and G.C. Rodriguez The prognostic significance of angiogenesis in epithelial ovarian carcinoma Clin Cancer Res 5 1999 587 591
8. J. Huang, J.O. Bae, J.P. Tsai, A. Kadenhe-Chiweshe, J. Papa, A. Lee, S. Zeng, Z.N. Kornfeld, P. Ullner, N. Zaghloul, E. Ioffe, S. Nandor, E. Burova, J. Holash, G. Thurston, J. Rudge, G.D. Yancopoulos, D.J. Yamashiro, and J.J. Kandel Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade Int J Oncol 34 2009 79 87
9. G. Bergers, and D. Hanahan Modes of resistance to anti-angiogenic therapy Nat Rev Cancer 8 2008 592 603
10. J.M. Ebos, C.R. Lee, and R.S. Kerbel Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy Clin Cancer Res 15 2009 5020 5025
11. H. Huang, A. Bhat, G. Woodnutt, and R. Lappe Targeting the ANGPT-TIE2 pathway in malignancy Nat Rev Cancer 10 2010 575 585
12. M.K. Brunckhorst, H. Wang, R. Lu, and Q. Yu Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis Cancer Res 70 2010 7283 7293
13. E. Fagiani, and G. Christofori Angiopoietins in angiogenesis Cancer Lett 328 2012 18 26
14. Y. Xu, and Q. Yu Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region J Biol Chem 276 2001 34990 34998
15. Y. Xu, Y.J. Liu, and Q. Yu Angiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycans J Biol Chem 279 2004 41179 41188
16. Y.K. Lau, L.B. Murray, S.S. Houshmandi, Y. Xu, D.H. Gutmann, and Q. Yu Merlin is a potent inhibitor of glioma growth Cancer Res 68 2008 5733 5742
17. L.B. Murray, Y.K. Lau, and Q. Yu Merlin is a negative regulator of human melanoma growth PLoS One 7 2012 e43295
18. C.E. Lewis, M. De Palma, and L. Naldini Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2 Cancer Res 67 2007 8429 8432
19. M. Iurlaro, M. Scatena, W.H. Zhu, E. Fogel, S.L. Wieting, and R.F. Nicosia Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins J Cell Sci 116 2003 3635 3643
20. L.F. Brown, B.J. Dezube, K. Tognazzi, H.F. Dvorak, and G.D. Yancopoulos Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma Am J Pathol 156 2000 2179 2183
21. M.J. Currie, S.P. Gunningham, K. Turner, C. Han, P.A. Scott, B.A. Robinson, W. Chong, A.L. Harris, and S.B. Fox Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia J Pathol 198 2002 502 510
22. W.S. Moon, H.S. Park, K.H. Yu, K.Y. Jang, M.J. Kang, H. Park, and A.S. Tarnawski Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis J Korean Med Sci 21 2006 272 278
23. H. Naora, and D.J. Montell Ovarian cancer metastasis: integrating insights from disparate model organisms Nat Rev Cancer 5 2005 355 366
24. T.N. Sato, Y. Qin, C.A. Kozak, and K.L. Audus Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system Proc Natl Acad Sci U S A 90 1993 9355 9358
25. H. Schnurch, and W. Risau Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage Development 119 1993 957 968
26. P. Saharinen, M. Bry, and K. Alitalo How do angiopoietins Tie in with vascular endothelial growth factors? Curr Opin Hematol 17 2010 198 205
27. G. Thurston, and C. Daly The complex role of angiopoietin-2 in the angiopoietin-tie signaling pathway Cold Spring Harb Perspect Med 2 2012 a006550
28. S. Paget The distribution of secondary growths in cancer of the breast. 1889 Cancer Metastasis Rev 8 1989 98 101
29. R.M. Bremnes, T. Donnem, S. Al-Saad, K. Al-Shibli, S. Andersen, R. Sirera, C. Camps, I. Marinez, and L.T. Busund The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer J Thorac Oncol 6 2011 209 217
30. Y. Gong, E. Scott, R. Lu, Y. Xu, W.K. Oh, and Q. Yu TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progression PLoS One 8 2013 e77366
31. A. Cardone, A. Tolino, R. Zarcone, G. Borruto Caracciolo, and E. Tartaglia Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer Panminerva Med 39 1997 174 177
32. S. Kawashiri, A. Tanaka, N. Noguchi, T. Hase, H. Nakaya, T. Ohara, K. Kato, and E. Yamamoto Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity Head Neck 31 2009 1346 1353
33. P. Surowiak, S. Suchocki, B. Gyorffy, T. Gansukh, A. Wojnar, A. Maciejczyk, M. Pudelko, and M. Zabel Stromal myofibroblasts in breast cancer: relations between their occurrence, tumor grade and expression of some tumour markers Folia Histochem Cytobiol 44 2006 111 116
34. J.J. Tomasek, G. Gabbiani, B. Hinz, C. Chaponnier, and R.A. Brown Myofibroblasts and mechano-regulation of connective tissue remodelling Nat Rev Mol Cell Biol 3 2002 349 363
35. L. Ronnov-Jessen, O.W. Petersen, and M.J. Bissell Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction Physiol Rev 76 1996 69 125
36. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
37. G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, and J. Holash Vascular-specific growth factors and blood vessel formation Nature 407 2000 242 248
38. J. Cai, H. Tang, L. Xu, X. Wang, C. Yang, S. Ruan, J. Guo, S. Hu, and Z. Wang Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness Carcinogenesis 33 2012 20 29
39. A. Orimo, P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson, and R.A. Weinberg Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 2005 335 348
40. M. Shimoda, K.T. Mellody, and A. Orimo Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression Semin Cell Dev Biol 21 2010 19 25
41. Y. Zhang, H. Tang, J. Cai, T. Zhang, J. Guo, D. Feng, and Z. Wang Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion Cancer Lett 303 2011 47 55
42. D. Fukumura, R. Xavier, T. Sugiura, Y. Chen, E.C. Park, N. Lu, M. Selig, G. Nielsen, T. Taksir, R.K. Jain, and B. Seed Tumor induction of VEGF promoter activity in stromal cells Cell 94 1998 715 725
43. S.Y. Sung, C.L. Hsieh, A. Law, H.E. Zhau, S. Pathak, A.S. Multani, S. Lim, I.M. Coleman, L.C. Wu, W.D. Figg, W.L. Dahut, P. Nelson, J.K. Lee, M.B. Amin, R. Lyles, P.A. Johnstone, F.F. Marshall, and L.W. Chung Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis Cancer Res 68 2008 9996 10003
44. P. Batard, P. Sansilvestri, C. Scheinecker, W. Knapp, N. Debili, W. Vainchenker, H.J. Buhring, M.N. Monier, E. Kukk, J. Partanen, M.T. Matikainen, R. Alitalo, J. Hatzfeld, and K. Alitalo The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells Blood 87 1996 2212 2220
45. M. Takahama, M. Tsutsumi, T. Tsujiuchi, K. Nezu, K. Kushibe, S. Taniguchi, Y. Kotake, and Y. Konishi Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas Clin Cancer Res 5 1999 2506 2510
46. B.M. Lichtenberger, P.K. Tan, H. Niederleithner, N. Ferrara, P. Petzelbauer, and M. Sibilia Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development Cell 140 2010 268 279
47. X. Chen, W. Fu, C.E. Tung, and N.L. Ward Angiopoietin-1 induces neurite outgrowth of PC12 cells in a Tie2-independent, [beta]1-integrin-dependent manner Neurosci Res 64 2009 348 354
48. S.M. Dallabrida, N.S. Ismail, E.A. Pravda, E.M. Parodi, R. Dickie, E.M. Durand, J. Lai, F. Cassiola, R.A. Rogers, and M.A. Rupnick Integrin binding angiopoietin-1 monomers reduce cardiac hypertrophy FASEB J 22 2008 3010 3023
49. Y. Imanishi, B. Hu, M.J. Jarzynka, P. Guo, E. Elishaev, I. Bar-Joseph, and S.Y. Cheng Angiopoietin-2 stimulates breast cancer metastasis through the {alpha}5{beta}1 integrin-mediated pathway Cancer Res 67 2007 4254 4263
50. R.S. Herbst, D. Hong, L. Chap, R. Kurzrock, E. Jackson, J.M. Silverman, E. Rasmussen, Y.N. Sun, D. Zhong, Y.C. Hwang, J.L. Evelhoch, J.D. Oliner, N. Le, and L.S. Rosen Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors J Clin Oncol 27 2009 3557 3565
51. D.M. Valenzuela, J.A. Griffiths, J. Rojas, T.H. Aldrich, P.F. Jones, H. Zhou, J. McClain, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, T. Huang, N. Papadopoulos, P.C. Maisonpierre, S. Davis, and G.D. Yancopoulos Angiopoietins 3 and 4: diverging gene counterparts in mice and humans Proc Natl Acad Sci U S A 96 1999 1904 1909